Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IPN01203 in Advanced Solid Tumours
NCT07213830Phase 2Recruiting
- Sponsor
- Ipsen
- Start
- Feb 2026
- Primary completion
- Jul 2032
- Modality
- Biologic
- Countries
- 4
01
Overview
A Phase 2 trial of IPN01203 in solid tumor, sponsored by Ipsen. Started Feb 2026; status: recruiting.
02
Drugs
IPN01203
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT07213830.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07213830.